Literature DB >> 2786001

Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy.

A Rodin1, A Duncan, H W Quartero, G Pistofidis, G Mashiter, K Whitaker, D Crook, J C Stevenson, M G Chapman, I Fogelman.   

Abstract

We measured serum alkaline phosphatase isoenzymes and osteocalcin levels in 40 healthy women at 4-week intervals throughout uncomplicated pregnancies and 6 weeks after delivery in 17 women. Serum bone alkaline phosphatase was significantly higher in the third trimester than in early pregnancy (P less than 0.001), and this elevation was still apparent at the end of the puerperium, suggesting increased bone turnover. Serum osteocalcin was not detected (less than 0.2 micrograms/L) after the first trimester in the majority of women, and it reappeared within 48 h after delivery. The disappearance of osteocalcin after the first trimester and its rapid reappearance after delivery suggest placental clearance of this peptide. We conclude that serum osteocalcin measurements cannot be used as a marker of bone metabolism during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786001     DOI: 10.1210/jcem-68-6-1123

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.

Authors:  D Holmberg-Marttila; A Leino; H Sievänen
Journal:  Osteoporos Int       Date:  2003-02-12       Impact factor: 4.507

2.  Post-partum hypercalcemia in hereditary hyperphosphatasia (juvenile Paget's disease).

Authors:  N Chosich; F Long; R Wong; D J Topliss; J R Stockigt
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

Review 3.  Impact of bone mineral measurements on osteoporosis.

Authors:  I Fogelman; A Rodin; G Blake
Journal:  Eur J Nucl Med       Date:  1990

4.  Diagnostic utility of heat stable alkaline phosphatase in hypertensive disorders of pregnancy.

Authors:  Reeta Rajagambeeram; Srinivasan Abu Raghavan; Seethesh Ghosh; Sharbari Basu; Ramesh Ramasamy; Sathish Babu Murugaiyan
Journal:  J Clin Diagn Res       Date:  2014-11-20

5.  Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits.

Authors:  H K Nielsen; K Brixen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

6.  Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.

Authors:  M P Whyte; M Landt; L M Ryan; R A Mulivor; P S Henthorn; K N Fedde; J D Mahuren; S P Coburn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 7.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

8.  Maternal zinc supplementation and growth in Peruvian infants.

Authors:  Lora L Iannotti; Nelly Zavaleta; Zulema León; Anuraj H Shankar; Laura E Caulfield
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

9.  Osteocalcin levels in patients with microprolactinoma before and during medical treatment.

Authors:  A Sartorio; A Conti; B Ambrosi; M Muratori; F Morabito; G Faglia
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.